findmyKOL
Clinical trialNCT01074125CompletedPhase 3Interventional

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

SponsorKeryx BiopharmaceuticalsEnrollment154End-Stage Renal DiseaseHyperphosphatemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • Rcmi- Clinical Research Center Medical Sciences Campus University of Puerto Rico

    Rio Piedras, PR, Puerto Rico

United States
  • Western Nephrology

    Westminster, Colorado, United States

  • Pines Clinical Research, Inc.

    Pembroke Pines, Florida, United States

  • Kidney Care Associates, Llc

    Augusta, Georgia, United States

  • Circle Medical Management

    Chicago, Illinois, United States

  • Western New England Renal & Transplant Associates

    Springfield, Massachusetts, United States

  • Brookdale Physician'S Dialysis Associates

    Brooklyn, New York, United States

  • Dci

    Cincinnati, Ohio, United States

  • Cleveland Clinical Foundation Fresenius East (fairhill)

    Cleveland, Ohio, United States

  • the Ohio State University Cramblett Medical Clinic

    Columbus, Ohio, United States

  • Southeast Renal Research Institute

    Chattanooga, Tennessee, United States

  • Meharry Medical College Clinical Research Center

    Nashville, Tennessee, United States

  • Nephrology Associates, Pc

    Nashville, Tennessee, United States

  • Vanderbilt University Medical Center Clinical Trials Center

    Nashville, Tennessee, United States

  • Kidney Associates

    Houston, Texas, United States

  • Centre Point Dialysis

    West Allis, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2010
Primary completion
30 Nov 2010
Completion
30 Nov 2010
Last update posted
4 Dec 2014
Registered enrollment
154
Registry id
NCT01074125

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.